Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$31.57 - $43.02 $3,914 - $5,334
124 New
124 $3,000
Q2 2023

Jul 18, 2023

SELL
$37.26 - $51.01 $27,386 - $37,492
-735 Reduced 51.72%
686 $27,000
Q1 2023

Apr 13, 2023

SELL
$41.44 - $59.32 $28,262 - $40,456
-682 Reduced 32.43%
1,421 $60,000
Q4 2022

Jan 23, 2023

SELL
$39.45 - $51.77 $1,814 - $2,381
-46 Reduced 2.14%
2,103 $0
Q3 2022

Oct 26, 2022

BUY
$27.8 - $40.12 $59,742 - $86,217
2,149 New
2,149 $80,000

Others Institutions Holding KROS

About Keros Therapeutics, Inc.


  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $403M
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.